Colgate-Palmolive (NYSE:CL) Shares Bought by XTX Topco Ltd

XTX Topco Ltd lifted its position in shares of Colgate-Palmolive (NYSE:CL - Free Report) by 132.4% during the 3rd quarter, according to its most recent disclosure with the SEC. The firm owned 10,137 shares of the company's stock after buying an additional 5,776 shares during the period. XTX Topco Ltd's holdings in Colgate-Palmolive were worth $1,052,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds have also modified their holdings of the company. Continuum Advisory LLC increased its position in Colgate-Palmolive by 46.5% during the second quarter. Continuum Advisory LLC now owns 394 shares of the company's stock worth $38,000 after purchasing an additional 125 shares during the last quarter. Reston Wealth Management LLC acquired a new stake in shares of Colgate-Palmolive in the third quarter worth $42,000. Capital Performance Advisors LLP acquired a new stake in shares of Colgate-Palmolive in the third quarter worth $53,000. Prospera Private Wealth LLC acquired a new stake in shares of Colgate-Palmolive in the third quarter worth $64,000. Finally, Gradient Investments LLC increased its position in shares of Colgate-Palmolive by 150.4% in the second quarter. Gradient Investments LLC now owns 666 shares of the company's stock worth $65,000 after acquiring an additional 400 shares in the last quarter. Hedge funds and other institutional investors own 80.41% of the company's stock.

Wall Street Analyst Weigh In

Several equities research analysts have recently issued reports on CL shares. Stifel Nicolaus lowered shares of Colgate-Palmolive from a "buy" rating to a "hold" rating and dropped their price objective for the stock from $105.00 to $101.00 in a research report on Monday, October 28th. JPMorgan Chase & Co. raised their price target on shares of Colgate-Palmolive from $113.00 to $114.00 and gave the company an "overweight" rating in a report on Friday, October 11th. UBS Group raised their price target on shares of Colgate-Palmolive from $119.00 to $122.00 and gave the company a "buy" rating in a report on Wednesday, September 4th. Piper Sandler assumed coverage on shares of Colgate-Palmolive in a report on Tuesday, September 24th. They set an "overweight" rating and a $121.00 price target for the company. Finally, Wells Fargo & Company lowered their price target on shares of Colgate-Palmolive from $100.00 to $92.00 and set an "underweight" rating for the company in a report on Monday, October 28th. One investment analyst has rated the stock with a sell rating, nine have given a hold rating and thirteen have assigned a buy rating to the company. According to data from MarketBeat, Colgate-Palmolive currently has a consensus rating of "Moderate Buy" and an average target price of $105.11.

Colgate-Palmolive Stock Performance

Shares of CL stock traded up $0.94 during trading hours on Tuesday, reaching $93.88. The stock had a trading volume of 4,324,841 shares, compared to its average volume of 4,385,220. The company has a debt-to-equity ratio of 9.46, a current ratio of 1.04 and a quick ratio of 0.68. Colgate-Palmolive has a twelve month low of $75.50 and a twelve month high of $109.30. The firm has a 50-day simple moving average of $96.33 and a 200-day simple moving average of $98.65. The firm has a market capitalization of $76.70 billion, a PE ratio of 26.90, a price-to-earnings-growth ratio of 3.36 and a beta of 0.43.

Colgate-Palmolive Announces Dividend

The company also recently disclosed a quarterly dividend, which was paid on Friday, November 15th. Investors of record on Friday, October 18th were issued a $0.50 dividend. The ex-dividend date of this dividend was Friday, October 18th. This represents a $2.00 dividend on an annualized basis and a dividend yield of 2.13%. Colgate-Palmolive's dividend payout ratio (DPR) is presently 57.31%.

Insider Buying and Selling

In other Colgate-Palmolive news, CFO Stanley J. Sutula III sold 45,410 shares of the firm's stock in a transaction dated Tuesday, November 5th. The shares were sold at an average price of $94.11, for a total transaction of $4,273,535.10. Following the transaction, the chief financial officer now owns 36,726 shares of the company's stock, valued at approximately $3,456,283.86. This trade represents a 55.29 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Corporate insiders own 0.37% of the company's stock.

Colgate-Palmolive Company Profile

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.